BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs2230926
,
BRCA1
,
T cell differentiation
,
Ischemia
,
Endothelial cell
,
Neocentromeres
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
insulin- like growth factor- 1 receptor
Summary
General Info
Curated Studies
Most Correlated Studies
L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
L1000 CMAP - Lung cancer A549 cells treated with ligand perturbagens
L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
IGF/IGF-1R signal pathway in pain: a promising therapeutic target.
Cryo-EM studies of the apo states of human IGF1R.
Decreased IGF1R attenuates senescence and improves function in pancreatic β-cells.
Association of IGF1R polymorphisms with kidney function-related traits.
Exosomal miR-223 promotes ARDS by targeting insulin-like growth factor 1 receptor: A cell communicat…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Study of Insulin-like Growth Factor (IGF)-Methotrexate Conjugate in the Treatment of Advanced Tumors…
Growth Hormone in a Patient With a Dominant-Negative GHR Mutation
Role of Adiponectine in Pathophysiology Ogf Diabetic Foot
MK-0646 Insulin Growth Factor 1 Receptor Antibody in Stage IIIb or IV Metastatic Non-Squamous Lung C…
Reducing Insulin, Growth Hormones, and Tumors
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ